IMDX
Insight Molecular Diagnostics Inc.
4.10$
+3.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.3% | -59.0% | -40.9% | +10.6% | +1,192.2% | +43.9% | -75.8% | -49.8% | +338.1% | -97.2% | +646.9% | – | |
| – | -5.2% | -27.6% | -58.8% | +20.4% | +1,270.8% | -8.8% | -79.3% | -28.0% | +431.4% | -0.9% | -87.1% | – | |
| – | -8.8% | -81.9% | +11.1% | +0.0% | +1,090.0% | +122.7% | -73.6% | -60.3% | +256.8% | -222.1% | – | – | |
| – | -10.3% | +5.8% | +6.1% | +14.8% | -19.9% | +29.6% | +12.2% | +18.2% | +50.3% | -21.1% | -2.5% | – | |
| – | -17.7% | +8.7% | -28.7% | +6.6% | +23.2% | -1.4% | -15.0% | -3.9% | +57.1% | -25.2% | -3.9% | – | |
| – | -21.1% | +37.7% | -49.7% | +189.7% | +152.3% | -76.3% | +25.5% | +9.8% | -6.6% | -6.9% | +18.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +7.1% | -46.7% | +287.5% | -3.2% | -3.3% | -13.8% | +16.0% | -10.3% | -11.5% | -13.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -81.2% | +849.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.